Chronic Imbalance? Gender Disparities in Gastroenterology Across a Decade of the Visceral Medicine Congress in Germany慢性失衡?德国内脏医学大会十年间胃肠病学领域的性别差异ZEITSCHRIFT FUR GASTROENTEROLOGIEIF1.62025-10-010OA
The implications of Industry-Funded Disease Awareness Campaigns in the Rare Disease SettingMAYO CLINIC PROCEEDINGSIF6.72021-09-010OAAI
The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009-2018BMC CANCERIF3.42021-08-036OAAI
After COVID-19, telemedicine may be used in addition to usual care and not in lieu of: Implications for health systemsINTERNATIONAL JOURNAL OF CANCERIF4.72021-08-021OAAI
N of 1 Data Sharing: The Impact of Data Sharing within the Hematology-Oncology Drug Products Division of the US FDATRENDS IN CANCERIF17.52021-05-012OAAI
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reformBMJ EVIDENCE-BASED MEDICINEIF7.62020-11-1117OAAI
A Timeline of Immune Checkpoint Inhibitor Aporovals in Small Cell Lung CancerTRENDS IN CANCERIF17.52020-09-016OAAI
The response rate of alternative treatments for drugs approved on the basis of response rateINTERNATIONAL JOURNAL OF CANCERIF4.72020-08-269OAAI
When are randomized controlled trials needed to assess novel anticancer drugs? An illustration based on the development of selpercatinib, a RET inhibitorANNALS OF ONCOLOGYIF65.42020-03-014OAAI
Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's ActionsMAYO CLINIC PROCEEDINGSIF6.72020-02-015PREAI
A method to determine if more than surrogate outcomes were improved: The EMR glitch experimentRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42020-01-011OAAI
A reality check of the accelerated approval of immune-checkpoint inhibitorsNATURE REVIEWS CLINICAL ONCOLOGYIF82.22019-08-0530PREAI
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversalsELIFEIF02019-06-1183OAAI
Testing for blinding in sham-controlled studies for procedural interventions: the third-party video methodCANADIAN MEDICAL ASSOCIATION JOURNALIF11.32019-03-105OAAI
Registration studies - when should patients be deemed ineligible for aggressive therapy?NATURE REVIEWS CLINICAL ONCOLOGYIF82.22019-02-182PREAI
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncologyEUROPEAN JOURNAL OF CANCERIF7.12019-01-01143PREAI
Direct-to-Consumer Genetic Testing The Implications of the US FDA's First Marketing Authorization for BRCA Mutation TestingJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552018-06-1946PREAI
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary ResultsJOURNAL OF RHEUMATOLOGYIF3.42018-02-0137OAAI
THE IMPA CT OF EXTERNAL PRICE REFERENCING WITHIN AND ACROSS A COUNTRY'S BORDERSVALUE IN HEALTHIF62016-11-010OAAI